IBDEI1HU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23892,0)
 ;;=I25.119^^107^1196^5
 ;;^UTILITY(U,$J,358.3,23892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23892,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,23892,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,23892,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,23893,0)
 ;;=I25.10^^107^1196^6
 ;;^UTILITY(U,$J,358.3,23893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23893,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,23893,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,23893,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,23894,0)
 ;;=F17.219^^107^1196^49
 ;;^UTILITY(U,$J,358.3,23894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23894,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,23894,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,23894,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,23895,0)
 ;;=Z51.5^^107^1196^62
 ;;^UTILITY(U,$J,358.3,23895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23895,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,23895,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,23895,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,23896,0)
 ;;=Z23.^^107^1196^26
 ;;^UTILITY(U,$J,358.3,23896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23896,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,23896,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,23896,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,23897,0)
 ;;=E11.65^^107^1196^18
 ;;^UTILITY(U,$J,358.3,23897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23897,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,23897,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,23897,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,23898,0)
 ;;=E11.649^^107^1196^19
 ;;^UTILITY(U,$J,358.3,23898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23898,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,23898,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,23898,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,23899,0)
 ;;=I16.0^^107^1196^42
 ;;^UTILITY(U,$J,358.3,23899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23899,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,23899,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,23899,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,23900,0)
 ;;=H54.8^^107^1196^45
 ;;^UTILITY(U,$J,358.3,23900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23900,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,23900,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,23900,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,23901,0)
 ;;=F10.10^^107^1196^2
 ;;^UTILITY(U,$J,358.3,23901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23901,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,23901,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,23901,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,23902,0)
 ;;=J30.9^^107^1196^3
 ;;^UTILITY(U,$J,358.3,23902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23902,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,23902,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,23902,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,23903,0)
 ;;=I48.0^^107^1196^7
 ;;^UTILITY(U,$J,358.3,23903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23903,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,23903,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,23903,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,23904,0)
 ;;=N18.1^^107^1196^9
